| Thursday, October 30, 2025 |
|
Esperanza Unveils New Milestone in Tokenized Economy
19:09 HKT/SGT
|
|
|
Esperanza展示代幣化經濟新里程
19:09 HKT/SGT
|
|
|
康哲藥業（867.HK;8A8.SG）長效抗IL-4Rα人源化單抗注射液MG-K10特應性皮炎適應症中國NDA已獲受理
18:27 HKT/SGT
|
|
|
康哲药业（867.HK;8A8.SG）长效抗IL-4Rα人源化单抗注射液MG-K10特应性皮炎适应症中国NDA已获受理
18:27 HKT/SGT
|
|
|
Universal Digital and ReYUU Japan Sign MOU to Develop Strategic Financing Framework
18:09 HKT/SGT
|
|
|
朗豪坊擴充共享辦公空間至38,000平方呎樓面面積
17:53 HKT/SGT
|
|
|
MHI-MS to Conduct Demonstration Testing of Vehicle Transport Robots at Nakagusuku Port in Okinawa
16:58 HKT/SGT
|
|
|
Everest Medicines Acquires Exclusive Greater China and Other Asian Country Rights to VIS-101, a Novel Bifunctional Biologic for Serious Eye Disorders
16:48 HKT/SGT
|
|
|
雲頂新耀與Visara簽訂協議 將在大中華區及其他亞洲市場開發及商業化VIS-101
16:36 HKT/SGT
|
|
|
云顶新耀与Visara签订协议 将在大中华区及其他亚洲市场开发及商业化VIS-101
16:36 HKT/SGT
|
|
|
DENSO Hosted a Press Briefing at JAPAN MOBILITY SHOW 2025
16:29 HKT/SGT
|
|
|
透雲生物簽訂人民幣10億元萊茵衣藻系列產品採購協議
15:12 HKT/SGT
|
|
|
透云生物签订人民币10亿元莱茵衣藻系列产品采购协议
15:12 HKT/SGT
|
|
|
Northeast Asia Video Summit Spotlights Global Content Strategies, Streaming Innovation, and the Future of Media Monetization
15:00 HKT/SGT
|
|
|
Eisai and Merck & Co., Inc., Rahway, NJ, USA Provide Update on Phase 3 LEAP012 Trial in Unresectable, Non-Metastatic Hepatocellular Carcinoma
13:43 HKT/SGT
|
|
|
Mazda Presents World Premiere of Two Vision Models at Japan Mobility Show 2025
13:33 HKT/SGT
|
|
|
Mazda Rolls Out New Version of Brand Symbol from Japan Mobility Show 2025
13:26 HKT/SGT
|
|
|
NEC and the Cambodian Mine Action Center Successfully Predict Landmine-Contaminated Areas in Cambodia Using AI
13:18 HKT/SGT
|
|
|
Overview of Honda CEO Speech at the Japan Mobility Show 2025
13:00 HKT/SGT
|
|
|
Honda Presents World Premiere of the Prototype of Honda 0 a, new SUV Model for Honda 0 Series at Japan Mobility Show 2025
10:55 HKT/SGT
|
|
|
賽力斯開啟招股 旗下問界品牌被譽為「中國的特斯拉」
10:55 HKT/SGT
|
|
|
赛力斯开启招股 旗下问界品牌被誉为「中国的特斯拉」
10:55 HKT/SGT
|
|
|
Honda Presents World Premiere of Super-ONE Prototype Compact EV at Japan Mobility Show 2025
10:50 HKT/SGT
|
|
|
產品與技術共築堅固護城河「中國的特斯拉」賽力斯招股進行時
10:46 HKT/SGT
|
|
|
产品与技术共筑坚固护城河「中国的特斯拉」赛力斯招股进行时
10:46 HKT/SGT
|
|
|
賽力斯赴港招股：問界「智慧重塑豪華」引領新能源趨勢
10:40 HKT/SGT
|
|
|
赛力斯赴港招股：问界「智慧重塑豪华」引领新能源趋势
10:40 HKT/SGT
|
|
|
Mitsubishi Motors Debuts Mitsubishi Elevance Concept and Adventure-Inspiring Lineup at Japan Mobility Show 2025
10:39 HKT/SGT
|
|
|
Fujitsu and PwC Japan partner on economic security measures for sovereign cloud solution
10:22 HKT/SGT
|
|
|
Hitachi Rail becomes world's first transportation firm to adopt new NVIDIA IGX Thor solution for real-time AI
10:00 HKT/SGT
|
|
|
| Wednesday, October 29, 2025 |
|
Universal Digital Inc.、ReYuu Japan株式会社への戦略的投資の完了を発表
23:00 HKT/SGT
|
|
|
MOVAとUSD1SWAP、ディバイ「Vision 2030」サミットでグローバルデジタル資産インフラの未来を定義
22:00 HKT/SGT
|
|
|
Universal Digital Inc. Announces Closing of Strategic Investment in ReYuu Japan Inc.
19:39 HKT/SGT
|
|
|
國泰君安國際助力滴普科技成功登陸港交所主板
14:00 HKT/SGT
|
|
|
Ecological Threat Report 2025: Extreme Wet-Dry Seasons Emerge as Critical Conflict Catalyst
13:00 HKT/SGT
|
|
|
Reclaims Global Positions for Next Phase of Growth with Successful Placement and Strong Sector Momentum
11:14 HKT/SGT
|
|
|
国泰君安国际助力滴普科技成功登陆港交所主板
10:30 HKT/SGT
|
|
|
GTJAI Assisted Deepexi Technology in Successfully Listing on the Main Board of the Hong Kong Stock Exchange
10:30 HKT/SGT
|
|
|
GTJAI Serves as the Sole Sponsor for CIG, Achieving the Largest IPO in the Telecommunications Equipment Sector across Both A-shares and H-shares Markets
10:27 HKT/SGT
|
|
|
國泰君安國際獨家保薦劍橋科技 成就A股H股通信設備行業最大規模IPO
10:27 HKT/SGT
|
|
|
国泰君安国际独家保荐剑桥科技 成就A股H股通信设备行业最大规模IPO
10:27 HKT/SGT
|
|
|
Olympus Introduces NBI+TXI(TM) Observation Mode to the EVIS X1(TM) Endoscopy System CV-1500 Video System Center
10:00 HKT/SGT
|
|
|
OTS Holdings Celebrates the Grand Opening of its New Manufacturing Facility, Ellaziq (Malaysia) Sdn. Bhd., in Johor, Malaysia; Marks Major Expansion in its Halal Production Capacity
09:20 HKT/SGT
|
|
|
Gannon & Scott has signed a definitive agreement to join Metalor Technologies
03:00 HKT/SGT
|
|
|
| Tuesday, October 28, 2025 |
|
Merck & Co., Inc. and Eisai Announce WELIREG(R) (belzutifan) Plus LENVIMA(R) (lenvatinib) Met Primary Endpoint of Progression-Free Survival (PFS) in Certain Previously Treated Patients With Advanced Renal Cell Carcinoma
23:30 HKT/SGT
|
|
|
|
|
|
